Drug Topics

JULY 21, 2025

In August 2024, the American Medical Association (AMA), the advocacy group for US physicians, wrote a letter to US Congress opposing legislation that would allow pharmacists to test and treat patients with specific illnesses. 2024 Sep 24;46:101088. August 9, 2024. Muscat NA, Sinclair P, Zapata T, et al. Lancet Reg Health Eur.

Specialty Pharmacies

Drug Topics

AUGUST 12, 2025

A team of investigators from the University of Maryland School of Pharmacy and Albertsons Companies conducted a study to see which marketing methods are the main factors that affect patients’ decisions to receive the RSV vaccine. For the study, a survey was given to eligible patients who came to the pharmacy.

Vaccines

Drug Topics

JULY 11, 2025

Pneumococcal Hemolytic Uremic Syndrome Increased Among Children Over Last 15 Years Brian Nowosielski June 18th 2025 Article Researchers explored the incidence of pneumococcal hemolytic uremic syndrome in children living in Sweden from January 2009 to December 2024.

Vaccines

Drug Topics

JULY 8, 2025

Recent Videos Related Content Flip The Pharmacy April Schedule & Sign-Up March 28th 2024 Article Check out these can't-miss Workflow Wednesdays sessions in April. Flip The Pharmacy March Schedule & Sign-Ups March 4th 2024 Article Check out these can't-miss Workflow Wednesdays sessions in March.

Health and Personal Care Stores

Drug Topics

JUNE 18, 2025

March 21, 2024. KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs. May 10, 2024. link] Recent Videos Related Content Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform Ashley Gallagher June 16th 2025 Article Providers can prescribe the 12.5 As obesity rates rise in the U.S.

Compounding

Drug Topics

JUNE 6, 2025

Updated October 11, 2024. Updated October 11, 2024. Updated July 15, 2024. May 15, 2024. The Immunization Action Coalition. Travel Vaccines. Accessed May 16, 2025. Travelers’ Health. Accessed May 16, 2025. Plan for Travel. Accessed May 16, 2025. Yellow Fever Vaccine. Accessed May 16, 2025.

Vaccines

Drug Topics

JUNE 11, 2025

From 1980 to 2024, the National Centers for Environmental Information reported 403 confirmed natural disaster events impacting weather or climate, totaling economic losses over $1 billion. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.

Health and Personal Care Stores

Drug Topics

JULY 9, 2025

The nation faced a pharmacist shortage in 2000, and then pharmacy schools expanded to meet the need,” wrote the University of Wisconsin School of Pharmacy. But in 2024, that number fell to just 2.8%.” They approached the 7 pharmacy schools in Pennsylvania and 4 were included in the final analysis. December 3, 2024.

Health and Personal Care Stores

Drug Topics

JUNE 30, 2025

In the cross-sectional study, investigators used data from the 2018 to 2024 Mental Health and Addiction Treatment Tracking Repository. However, data on low-dose initiation compared with traditional initiation is still limited.

Compounding

Drug Topics

JULY 22, 2025

2 Glucagon-like peptide-1 (GLP-1) receptor agonists keep growing in popularity, and at the American Diabetes Association’s 85th Scientific Sessions, investigators showed the increase in pediatric patients with type 2 diabetes from 2019 to 2024. in 2024, according to the results. in 2019 to 60.9% Approximately 53.9% Approximately 20.3%

Specialty Pharmacies

Drug Topics

JUNE 20, 2025

Pneumococcal Burden Remains Despite Immunization Expansion Ashley Gallagher June 9th 2025 Article The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.

Vaccines

Drug Topics

JUNE 6, 2025

December 18, 2024. link] Recent Videos Related Content FDA Grants Expanded Interchangeability Designation to Yuflyma Ashley Gallagher May 23rd 2025 Article Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.

FDA

Drug Topics

JULY 2, 2025

3,4 Since then, several other formulations have received FDA approval, leading to research developments of multiple GLP-1s for treating people with overweight or obesity. April 4, 2024. Innovators who fought to unlock GLP-1 drugs for obesity awarded Mani L. Bhaumik Breakthrough of the Year Award. Accessed July 1, 2025.

Compounding

Drug Topics

JULY 10, 2025

PwC’s 2024 Voice of the Customer report found that 80% of consumers are willing to pay more for sustainably produced or sourced goods, despite overall rising costs. sustainability premium, even as cost-of-living and inflationary concerns weigh: PwC 2024 Voice of the Consumer Survey. Newsletter Pharmacy practice is always changing.

Health and Personal Care Stores

Drug Topics

AUGUST 11, 2025

July 2, 2024. link] Newsletter Pharmacy practice is always changing. JAMA Netw Open. 2025;8(8):e2526013. doi:10.1001/jamanetworkopen.2025.26013 2025.26013 2. Buss Preszler L. Health benefits of semaglutide—beyond weight loss. Mayo Clinic Press. Accessed August 11, 2025.

Specialty Pharmacies

Drug Topics

JULY 2, 2025

2024 Nov 15:dgae778. Tillman JB, Beck RW, Polonsky WH, et al. Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A Six-Month Analysis. J Clin Endocrinol Metab. doi: 10.1210/clinem/dgae778. Epub ahead of print. PMID: 39546625.

Patient Care

Drug Topics

JUNE 18, 2025

Published 2024 Nov 25. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025. Eggers S, Hoggarth ZE, Nagdeo K, et al. Food Insecurity Modifies the Association Between the Gut Microbiome and the Risk of Cognitive Impairment in Adults. rs-5486286. doi:10.21203/rs.3.rs-5486286/v1 rs-5486286/v1 3. Drug Topics.

Communication

Drug Topics

JULY 14, 2025

Dynamics that have become apparent during 2024 have driven significant revisions to the outlook, and in this report, the drivers of change in medicine spending over the next 5 years are deconstructed to enable better understanding,” wrote IQVIA. There [were] up to 48 novel drugs launched in the US in 2024; 31 of them were orphan drugs.

Immunization

Pharmacy Times

AUGUST 12, 2025

Published May 6, 2024. Pharmacy Times. Published March 22, 2024. FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia. Pharmacy Times. Published June 18, 2024. Last Updated October 2, 2024. Published October 21, 2024. Accessed August 11, 2025. Gallagher A.

Immunization

Pharmacy Times

AUGUST 6, 2025

Pharmacies enhance vaccine access and education, offering convenient vaccination opportunities and personalized counseling to counter hesitancy. According to the CDC, national kindergarten vaccination coverage dropped to 93% in the 2023-2024 school year, down from prepandemic levels of approximately 95%. October 2, 2024.

Vaccines

Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease. J Natl Med Assoc. 2019;111(5):540-545. doi:10.1016/j.jnma.2019.04.011 Subscribe Now!

Vaccines

Drug Topics

JULY 18, 2025

The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 “The FDA approval is a positive step toward driving prevention of this painful disease, and as a practicing pharmacist I welcome the availability of this new presentation.”

Vaccines

Drug Topics

JULY 29, 2025

1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 Image Credit: Jesse B/peopleimages.com - stock.adobe.com In the study, eligible patients from Denmark who previously had 3 or more COVID-19 doses received the 2024-2025 JN.1 1 lineage did not increase the risk of 29 adverse events of special interest.

Vaccines

Drug Topics

AUGUST 12, 2025

1 The FDA recommended that the US Drug Enforcement Administration (DEA) move medical marijuana from Schedule I to Schedule III. 2 This determination was based on the FDA’s evaluation of abuse potential, dependency, and accepted medical use for marijuana. Medical marijuana is defined as cannabis that contains no more than 0.3%

Specialty Pharmacies

Pharmacy Times

JULY 25, 2025

Last Updated October 26, 2024. Last Updated October 4, 2024. Pneumococcal disease­­—pneumococcal vaccine recommendations. Accessed July 23, 2025. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Accessed July 23, 2025. Hong K, Zhou F, Tsai Y, et al.

Vaccines

Pharmacy Times

JULY 22, 2025

Importantly, Novavax received FDA approval in May 2025 with restrictions: It is approved for individuals 65 years and older and patients aged 12 to 64 years with at least 1 health condition that puts them at risk for severe COVID-19. September 17, 2024. August 30, 2024. October 16, 2024. Accessed May 29, 2025.

Vaccines

Drug Topics

AUGUST 2, 2025

The FDA approved a label update for inclisiran (Leqvio), which can now be used as a monotherapy along with diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia. The FDA requested the label update due to data on the therapy’s ability to lower LDL-C. REFERENCES 1. News release.

Labelling

Pharmacy Times

JULY 16, 2025

14,15 Lung Cancer Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post Progression Tarlatamab has shown promising efficacy in relapsed SCLC based on the initial single-arm trial findings, leading to an FDA approval in 2024, but challenges with administration have limited its widespread adoption.

HIV Treatment and Prevention Agents

Drug Topics

JUNE 23, 2025

Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Health and Personal Care Stores

Drug Topics

JULY 17, 2025

November 8, 2024. August 30, 2024. link] Newsletter Pharmacy practice is always changing. The impact of pharmacist-led interventions on the treatment of COPD patients. Med Princ Pract. 2025; [link] 2. What is COPD? National Heart, Lung, and Blood Institute. Accessed July 17, 2025. Mayo Clinic Staff. Mayo Clinic.

Specialty Pharmacies

Pharmacy Times

AUGUST 5, 2025

During the 2023-2024 influenza season, only 44.9% September 20, 2024. The following are suggestions for pharmacists looking to utilize community connections to fight influenza. Meet Communities Where They Are Although influenza vaccines are widely available, vaccination rates remain below national goals. Healthy People 2030.

Vaccines

Pharmacy Times

AUGUST 1, 2025

1 The vertical integration in the business of care delivery has fostered alignments in payers, PBMs, and specialty pharmacies that often inflate prices and delay and detour appropriate therapy. In doing so, the law will prevent PBMs from steering patients to their own higher-cost specialty pharmacies. April 9, 2024.

Specialty Pharmacies

Pharmacy Times

AUGUST 7, 2025

SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. 4 By integrating FDA's new labeling requirements and CDC's framework into daily practice, pharmacists can significantly lessen opioid risk. REFERENCES 1. Published 2025.

Labelling

Drug Topics

JUNE 19, 2025

Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

CPhT

Pharmacy Times

AUGUST 11, 2025

8 Another study in the Journal of Managed Care & Specialty Pharmacy demonstrated that pharmacist-led MTM programs resulted in better medication adherence and lower health care costs. December 15, 2024. Updated September 10, 2024. Community-based Care Transitions Program. Centers for Medicare & Medicaid Services.

Hospitals

Drug Topics

JUNE 17, 2025

Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Community Pharmacies

Pharmacy Times

JUNE 27, 2025

SHOW MORE The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma. Mann School of Pharmacy and Pharmaceutical Sciences. For this application, the FDA collaborated with the Australian Therapeutic Goods Administration, Health Canada, and Switzerland’s Swissmedic.

FDA